Innoviva, Inc.
US ˙ NasdaqGS ˙ US45781M1018

SecurityINVA / Innoviva, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership109,090 shares
Latest Disclosed Value $ 2,191,618
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series reports 14.38% increase in ownership of INVA / Innoviva, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 109,090 shares of Innoviva, Inc. (US:INVA) valued at $2,191,618 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 95,377 shares of Innoviva, Inc.. This represents a change in shares of 14.38% during the quarter. The current value of the position is $2,456,707 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Innoviva EC US45781M1018 109,090 13,713 14.38 2,192 26.72 0.0492
2025-05-28 2025-03-31 NP Innoviva EC US45781M1018 95,377 2,477 2.67 1,729 7.32 0.0415
2025-02-25 2024-12-31 NP Innoviva EC US45781M1018 92,900 -16,174 -14.83 1,612 -23.50 0.0352
2024-11-26 2024-09-30 NP Innoviva EC US45781M1018 109,074 -2,796 -2.50 2,106 14.83 0.0398
2024-08-26 2024-06-30 NP Innoviva EC US45781M1018 111,870 9,594 9.38 1,835 17.72 0.0374
2024-05-28 2024-03-31 NP Innoviva EC US45781M1018 102,276 -6,756 -6.20 1,559 -10.87 0.0325
2024-02-26 2023-12-31 NP Innoviva EC US45781M1018 109,032 74,665 217.26 1,749 1,157.55 0.0373
2024-02-26 2023-12-31 NP Theseus Pharmaceuticals EC US88369M1018 34,367 -67,836 -66.37 139 -89.53 0.0030
2023-11-28 2023-09-30 NP Innoviva EC US45781M1018 102,203 67,836 197.39 1,328 1,342.39 0.0346
2023-11-28 2023-09-30 NP Theseus Pharmaceuticals EC US88369M1018 34,367 -72,073 -67.71 92 -93.21 0.0024
2023-08-25 2023-06-30 NP Innoviva EC US45781M1018 106,440 72,073 209.72 1,355 323.13 0.0321
2023-08-25 2023-06-30 NP Theseus Pharmaceuticals EC US88369M1018 34,367 -65,465 -65.58 321 -71.50 0.0076
2023-05-26 2023-03-31 NP Innoviva EC US45781M1018 99,832 72,425 264.26 1,123 362.14 0.0299
2023-05-26 2023-03-31 NP Theseus Pharmaceuticals EC US88369M1018 27,407 -72,425 -72.55 243 -81.62 0.0065
2023-02-24 2022-12-31 NP Innoviva EC US45781M1018 99,832 75,619 312.31 1,323 1,001.67 0.0364
2023-02-24 2022-12-31 NP Theseus Pharmaceuticals EC US88369M1018 24,213 -76,109 -75.86 121 -89.69 0.0033
2022-11-25 2022-09-30 NP Innoviva EC US45781M1018 100,322 70,200 233.05 1,165 568.97 0.0334
2022-11-25 2022-09-30 NP Theseus Pharmaceuticals EC US88369M1018 30,122 -67,632 -69.19 175 -87.93 0.0050
2022-08-25 2022-06-30 NP Innoviva EC US45781M1018 97,754 79,353 431.24 1,443 1,327.72 0.0398
2022-08-25 2022-06-30 NP Theseus Pharmaceuticals EC US88369M1018 18,401 -48,688 -72.57 102 -92.22 0.0028
2022-05-26 2022-03-31 NP Innoviva EC US45781M1018 67,089 48,688 264.59 1,298 512.26 0.0302
2022-05-26 2022-03-31 NP Theseus Pharmaceuticals EC US88369M1018 18,401 -47,109 -71.91 212 -81.24 0.0049
2022-02-25 2021-12-31 NP Innoviva EC US45781M1018 65,510 50,600 339.37 1,130 497.88 0.0245
2022-02-25 2021-12-31 NP Theseus Pharmaceuticals EC US88369M1018 14,910 -55,035 -78.68 189 -83.82 0.0041
2021-11-24 2021-09-30 NP Innoviva EC US45781M1018 69,945 -27,548 -28.26 1,169 -10.64 0.0257
2021-08-26 2021-06-30 NP Innoviva EC US45781M1018 97,493 0 0.00 1,307 12.19 0.0280
2021-05-27 2021-03-31 NP Innoviva EC US45781M1018 97,493 7,085 7.84 1,165 4.02 0.0264
2021-02-25 2020-12-31 NP Innoviva EC US45781M1018 90,408 -16,294 -15.27 1,120 0.45 0.0287
2020-11-25 2020-09-30 NP Innoviva EC US45781M1018 106,702 0 0.00 1,115 -25.22 0.0358
2020-08-27 2020-06-30 NP Innoviva EC US45781M1018 106,702 1,697 1.62 1,492 20.83 0.0488
2020-06-01 2020-03-31 NP Innoviva EC US45781M1018 105,005 6,765 6.89 1,235 -11.29 0.0505
2020-02-27 2019-12-31 NP Innoviva EC 45781M101 98,240 -935 -0.94 1,391 33.11 0.0418
2019-11-27 2019-09-30 NP Innoviva EC US45781M1018 99,175 99,175 1,045 0.0346
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.